Q2 2023 Holdings
Filed 2023-08-14 | 47 holdings | $418.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acelyrin Inc | COM | 00445A100 | $86.9M | 4,158,638 | 20.8% |
| Harrow Health Inc(HROW) | COM | 415858109 | $71.9M | 3,775,000 | 17.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $29.8M | 5,780,000 | 7.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $16.0M | 1,580,000 | 3.8% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $15.2M | 845,000 | 3.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $14.2M | 352,650 | 3.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $12.9M | 540,000 | 3.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $12.1M | 735,000 | 2.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $9.8M | 415,000 | 2.3% |
| Morphosys AG | SPONSORED ADS | 617760202 | $9.0M | 1,209,380 | 2.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.8M | 177,000 | 2.1% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $8.0M | 2,285,000 | 1.9% |
| Geron Corp(GERN) | COM | 374163103 | $7.5M | 2,350,000 | 1.8% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $6.8M | 625,000 | 1.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.5M | 720,000 | 1.6% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $6.4M | 2,692,594 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $6.3M | 815,000 | 1.5% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $6.2M | 566,700 | 1.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $5.9M | 570,000 | 1.4% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $5.6M | 543,500 | 1.3% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $5.6M | 597,500 | 1.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.2M | 217,000 | 1.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $4.9M | 120,000 | 1.2% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $4.5M | 570,700 | 1.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $4.4M | 1,390,000 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.2M | 130,000 | 1.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $4.1M | 1,701,500 | 1.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.0M | 3,370,000 | 1.0% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $4.0M | 221,700 | 1.0% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $3.6M | 445,000 | 0.9% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $3.5M | 380,000 | 0.8% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $3.2M | 1,785,000 | 0.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.0M | 421,000 | 0.7% |
| Spectrum Pharmaceuticals(STXS) | COM NEW | 85916J409 | $3.0M | 3,074,995 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.5M | 305,000 | 0.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $1.9M | 675,000 | 0.5% |
| Fortress Biotech Inc | COM | 34960Q109 | $1.8M | 3,310,000 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $1.4M | 307,000 | 0.3% |
| Black Diamond Therapeutics(BDTX) | COM | 09203E105 | $1.4M | 275,000 | 0.3% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $1.4M | 4,764,508 | 0.3% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $1.1M | 653,000 | 0.3% |
| Jasper(JNCEEUR) | COM | 481116101 | $917.8K | 669,944 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $758.9K | 102,000 | 0.2% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $594.8K | 275,000 | 0.1% |
| IGM Biosciiences Inc(1K0) | COM | 449585108 | $586.1K | 63,500 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $473.9K | 143,600 | 0.1% |
| Kezar Life Sciences Inc | COM | 49372L100 | $242.1K | 98,796 | 0.1% |